Open AccessPatients with breath test positive are necessary to be identified from irritable bowel syndrome: a clinical trial based on microbiomics and rifaximin sensitivity
Author(s) -
Zuojing Liu,
Shiwen Zhu,
Meibo He,
Mo Li,
Hui Wei,
Lu Zhang,
Qinghua Sun,
Qiong Jia,
Nan Hu,
Yuan Fang,
Lijin Song,
C. Zhou,
Heqing Tao,
John Y. Kao,
Huaiqiu Zhu,
Chung Owyang,
Liping Duan
Publication year - 2022
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000002294
Subject(s) - rifaximin , irritable bowel syndrome , gastroenterology , medicine , diarrhea , gut flora , small intestinal bacterial overgrowth , antibiotics , immunology , microbiology and biotechnology , biology